Madopar HBS in fluctuating Parkinsonian patients: two-year treatment
Identifieur interne :
002D54 ( PascalFrancis/Curation );
précédent :
002D53;
suivant :
002D55
Madopar HBS in fluctuating Parkinsonian patients: two-year treatment
Auteurs : G. Pezzoli ;
S. Tesei ;
C. Ferrante ;
E. Cossutta ;
A. Zecchinelli ;
G. ScarlatoSource :
-
Movement disorders [ 0885-3185 ] ; 1988.
RBID : Pascal:89-0022213
Descripteurs français
- Pascal (Inist)
- Antiparkinsonien,
Forme libération contrôlée,
Parkinson maladie,
Fluctuation,
Trouble moteur,
Formulation,
Dopa,
Bensérazide,
Chimiothérapie,
Long terme,
Forme libération contrôlée,
Rythme administration,
Traitement,
Système nerveux pathologie,
Homme.
- Wicri :
English descriptors
- KwdEn :
- Administration schedule,
Antiparkinson agent,
Chemotherapy,
Controlled release form,
Dopa,
Fluctuations,
Formulation,
Human,
Long term,
Motor system disorder,
Nervous system diseases,
Parkinson disease,
Treatment.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 3 |
|---|
| A06 | | | | @2 1 |
|---|
| A08 | 01 | 1 | ENG | @1 Madopar HBS in fluctuating Parkinsonian patients: two-year treatment |
|---|
| A11 | 01 | 1 | | @1 PEZZOLI (G.) |
|---|
| A11 | 02 | 1 | | @1 TESEI (S.) |
|---|
| A11 | 03 | 1 | | @1 FERRANTE (C.) |
|---|
| A11 | 04 | 1 | | @1 COSSUTTA (E.) |
|---|
| A11 | 05 | 1 | | @1 ZECCHINELLI (A.) |
|---|
| A11 | 06 | 1 | | @1 SCARLATO (G.) |
|---|
| A14 | 01 | | | @1 Univ. Milano, ist. clin. neurologica @2 Milano @3 ITA @Z A11011000 |
|---|
| A20 | | | | @1 37-45 |
|---|
| A21 | | | | @1 1988 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 CNRS @2 20953 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 22 ref. |
|---|
| A47 | 01 | 1 | | @0 89-0022213 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B02B06 |
|---|
| C03 | 01 | X | FRE | @0 Antiparkinsonien |
|---|
| C03 | 02 | X | FRE | @0 Forme libération contrôlée |
|---|
| C03 | 03 | X | FRE | @0 Parkinson maladie |
|---|
| C03 | 04 | X | FRE | @0 Fluctuation |
|---|
| C03 | 05 | X | FRE | @0 Trouble moteur |
|---|
| C03 | 06 | X | FRE | @0 Formulation |
|---|
| C03 | 07 | X | FRE | @0 Dopa |
|---|
| C03 | 08 | X | FRE | @0 Bensérazide |
|---|
| C03 | 09 | X | FRE | @0 Chimiothérapie |
|---|
| C03 | 10 | X | FRE | @0 Long terme |
|---|
| C03 | 17 | X | FRE | @0 Forme libération contrôlée |
|---|
| C03 | 18 | X | FRE | @0 Rythme administration |
|---|
| C03 | 19 | X | FRE | @0 Traitement |
|---|
| C03 | 20 | X | FRE | @0 Système nerveux pathologie |
|---|
| C03 | 21 | X | FRE | @0 Homme |
|---|
| C03 | 01 | X | ENG | @0 Antiparkinson agent |
|---|
| C03 | 02 | X | ENG | @0 Controlled release form |
|---|
| C03 | 03 | X | ENG | @0 Parkinson disease |
|---|
| C03 | 04 | X | ENG | @0 Fluctuations |
|---|
| C03 | 05 | X | ENG | @0 Motor system disorder |
|---|
| C03 | 06 | X | ENG | @0 Formulation |
|---|
| C03 | 07 | X | ENG | @0 Dopa |
|---|
| C03 | 09 | X | ENG | @0 Chemotherapy |
|---|
| C03 | 10 | X | ENG | @0 Long term |
|---|
| C03 | 17 | X | ENG | @0 Controlled release form |
|---|
| C03 | 18 | X | ENG | @0 Administration schedule |
|---|
| C03 | 19 | X | ENG | @0 Treatment |
|---|
| C03 | 20 | X | ENG | @0 Nervous system diseases |
|---|
| C03 | 21 | X | ENG | @0 Human |
|---|
| C03 | 01 | X | SPA | @0 Antiparkinsoniano |
|---|
| C03 | 02 | X | SPA | @0 Forma liberación controlada |
|---|
| C03 | 03 | X | SPA | @0 Parkinson enfermedad |
|---|
| C03 | 04 | X | SPA | @0 Fluctuación |
|---|
| C03 | 05 | X | SPA | @0 Trastorno motor |
|---|
| C03 | 06 | X | SPA | @0 Formulación |
|---|
| C03 | 07 | X | SPA | @0 Dopa |
|---|
| C03 | 09 | X | SPA | @0 Quimioterapia |
|---|
| C03 | 10 | X | SPA | @0 Largo plazo |
|---|
| C03 | 17 | X | SPA | @0 Forma liberación controlada |
|---|
| C03 | 18 | X | SPA | @0 Ritmo administración |
|---|
| C03 | 19 | X | SPA | @0 Tratamiento |
|---|
| C03 | 20 | X | SPA | @0 Sistema nervioso patología |
|---|
| C03 | 21 | X | SPA | @0 Hombre |
|---|
| N21 | | | | @1 811 |
|---|
| N82 | | | | @1 NBS |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003A71
Links to Exploration step
Pascal:89-0022213
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Madopar HBS in fluctuating Parkinsonian patients: two-year treatment</title>
<author><name sortKey="Pezzoli, G" sort="Pezzoli, G" uniqKey="Pezzoli G" first="G." last="Pezzoli">G. Pezzoli</name>
</author><author><name sortKey="Tesei, S" sort="Tesei, S" uniqKey="Tesei S" first="S." last="Tesei">S. Tesei</name>
</author><author><name sortKey="Ferrante, C" sort="Ferrante, C" uniqKey="Ferrante C" first="C." last="Ferrante">C. Ferrante</name>
</author><author><name sortKey="Cossutta, E" sort="Cossutta, E" uniqKey="Cossutta E" first="E." last="Cossutta">E. Cossutta</name>
</author><author><name sortKey="Zecchinelli, A" sort="Zecchinelli, A" uniqKey="Zecchinelli A" first="A." last="Zecchinelli">A. Zecchinelli</name>
</author><author><name sortKey="Scarlato, G" sort="Scarlato, G" uniqKey="Scarlato G" first="G." last="Scarlato">G. Scarlato</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">89-0022213</idno>
<date when="1988">1988</date>
<idno type="stanalyst">PASCAL 89-0022213 INIST</idno>
<idno type="RBID">Pascal:89-0022213</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003A71</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002D54</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Madopar HBS in fluctuating Parkinsonian patients: two-year treatment</title>
<author><name sortKey="Pezzoli, G" sort="Pezzoli, G" uniqKey="Pezzoli G" first="G." last="Pezzoli">G. Pezzoli</name>
</author><author><name sortKey="Tesei, S" sort="Tesei, S" uniqKey="Tesei S" first="S." last="Tesei">S. Tesei</name>
</author><author><name sortKey="Ferrante, C" sort="Ferrante, C" uniqKey="Ferrante C" first="C." last="Ferrante">C. Ferrante</name>
</author><author><name sortKey="Cossutta, E" sort="Cossutta, E" uniqKey="Cossutta E" first="E." last="Cossutta">E. Cossutta</name>
</author><author><name sortKey="Zecchinelli, A" sort="Zecchinelli, A" uniqKey="Zecchinelli A" first="A." last="Zecchinelli">A. Zecchinelli</name>
</author><author><name sortKey="Scarlato, G" sort="Scarlato, G" uniqKey="Scarlato G" first="G." last="Scarlato">G. Scarlato</name>
</author><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1988">1988</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration schedule</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Controlled release form</term>
<term>Dopa</term>
<term>Fluctuations</term>
<term>Formulation</term>
<term>Human</term>
<term>Long term</term>
<term>Motor system disorder</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Forme libération contrôlée</term>
<term>Parkinson maladie</term>
<term>Fluctuation</term>
<term>Trouble moteur</term>
<term>Formulation</term>
<term>Dopa</term>
<term>Bensérazide</term>
<term>Chimiothérapie</term>
<term>Long terme</term>
<term>Forme libération contrôlée</term>
<term>Rythme administration</term>
<term>Traitement</term>
<term>Système nerveux pathologie</term>
<term>Homme</term>
</keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Madopar HBS in fluctuating Parkinsonian patients: two-year treatment</s1>
</fA08><fA11 i1="01" i2="1"><s1>PEZZOLI (G.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>TESEI (S.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>FERRANTE (C.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>COSSUTTA (E.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>ZECCHINELLI (A.)</s1>
</fA11><fA11 i1="06" i2="1"><s1>SCARLATO (G.)</s1>
</fA11><fA14 i1="01"><s1>Univ. Milano, ist. clin. neurologica</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>A11011000</sZ>
</fA14><fA20><s1>37-45</s1>
</fA20><fA21><s1>1988</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>CNRS</s1>
<s2>20953</s2>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>22 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>89-0022213</s0>
</fA47><fA64 i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Forme libération contrôlée</s0>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Fluctuation</s0>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Trouble moteur</s0>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Formulation</s0>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Dopa</s0>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Bensérazide</s0>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Long terme</s0>
</fC03><fC03 i1="17" i2="X" l="FRE"><s0>Forme libération contrôlée</s0>
</fC03><fC03 i1="18" i2="X" l="FRE"><s0>Rythme administration</s0>
</fC03><fC03 i1="19" i2="X" l="FRE"><s0>Traitement</s0>
</fC03><fC03 i1="20" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC03><fC03 i1="21" i2="X" l="FRE"><s0>Homme</s0>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Controlled release form</s0>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Fluctuations</s0>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Motor system disorder</s0>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Formulation</s0>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Dopa</s0>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Long term</s0>
</fC03><fC03 i1="17" i2="X" l="ENG"><s0>Controlled release form</s0>
</fC03><fC03 i1="18" i2="X" l="ENG"><s0>Administration schedule</s0>
</fC03><fC03 i1="19" i2="X" l="ENG"><s0>Treatment</s0>
</fC03><fC03 i1="20" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC03><fC03 i1="21" i2="X" l="ENG"><s0>Human</s0>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Forma liberación controlada</s0>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Fluctuación</s0>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Trastorno motor</s0>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Formulación</s0>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Dopa</s0>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Largo plazo</s0>
</fC03><fC03 i1="17" i2="X" l="SPA"><s0>Forma liberación controlada</s0>
</fC03><fC03 i1="18" i2="X" l="SPA"><s0>Ritmo administración</s0>
</fC03><fC03 i1="19" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03><fC03 i1="20" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC03><fC03 i1="21" i2="X" l="SPA"><s0>Hombre</s0>
</fC03><fN21><s1>811</s1>
</fN21><fN82><s1>NBS</s1>
</fN82>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002D54 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002D54 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:89-0022213
|texte= Madopar HBS in fluctuating Parkinsonian patients: two-year treatment
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
